tazobactam has been researched along with Infections, Respiratory in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WT; DeRyke, CA; Kazmierczak, KM; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K | 1 |
| Alves, V; Cantón, R; Chaves, C; Diogo, J; Ferreira, R; García-Castillo, M; García-Fernández, S; Gonçalves, E; Melo-Cristino, J; Paixão, L; Pássaro, L; Pinto, MF; Ramalheira, E; Sancho, L; Silva, D; Vieira, AR | 1 |
| Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
| Collings, H; Dillon, R; Enstone, A; Palmer, T; Puzniak, L | 1 |
| Cantón, R; García-Castillo, M; García-Fernández, S; Hernández-García, M; Pássaro, L | 1 |
| Arena, F; Bassetti, M; D'Andrea, MM; Di Pilato, V; Giani, T; Henrici De Angelis, L; Pollini, S; Rossolini, GM | 1 |
| Bodro, M; Fresco, L; Marco, F; Martínez, JA; Paredes, S; Soriano, A; Xipell, M | 1 |
| Chaves, F; Lora-Tamayo, J; Orellana, MÁ; Recio, R; Viedma, E; Villa, J | 1 |
| Chhibba, A; Nayak, U; Patankar, M; Sequeira, L; Sukumaran, S | 1 |
| Jones, RN | 1 |
| Hiraga, Y; Inoue, H; Kawaguchi, S; Kawahara, M; Ohmichi, M; Oizumi, K; Saito, A; Sano, N; Sigematsu, H; Tanaka, F | 1 |
| Baughman, R; Boylen, CT; Chan, JC; Charan, NB; Cormier, YC; Erickson, A; Grossman, R; Kirmani, N; Shlaes, DM; Suh, B | 1 |
| Sanders, CV | 1 |
| Ajana, F; Beuscart, C; Chidiac, C; Lecocq, P; Leroy, O; Mouton, Y; Senneville, E | 1 |
| Wise, R | 1 |
| Chen, Y; Gao, L; Hou, F; Li, J | 1 |
| Amato, R; Andò, F; Azzaro, R; Bellissima, P; Cicciarella, S; Covelli, I; Delia, S; Fogliani, V; Fraschini, F; Girbino, G; Jacoviello, C; Laganà, P; Magrì, M; Maierna, G; Maria, GD; Marone, P; Messina, G; Muscianisi, G; Napoletano, G; Pela, R; Pezza, A; Rizza, S; Rossi, A; Sabato, V; Sanguinetti, C; Tedeschi, D; Varotto, F; Viola, B; Vitale, S | 1 |
2 review(s) available for tazobactam and Infections, Respiratory
| Article | Year |
|---|---|
Real-world use of ceftolozane/tazobactam: a systematic literature review.
Topics: Cephalosporins; Comorbidity; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections | 2021 |
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam | 1995 |
5 trial(s) available for tazobactam and Infections, Respiratory
| Article | Year |
|---|---|
[A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Chronic Disease; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1995 |
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam; Ticarcillin | 1994 |
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1994 |
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.
Topics: Abdomen; Adult; Bacteremia; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Skin Diseases, Infectious; Tazobactam | 1993 |
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections | 1998 |
10 other study(ies) available for tazobactam and Infections, Respiratory
| Article | Year |
|---|---|
In vitro activity of ceftolozane/tazobactam against Gram-negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries-SMART 2017-2019.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Meropenem; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Thailand | 2022 |
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intraabdominal Infections; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections | 2020 |
Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Respiratory Tract Infections; Tazobactam; United States | 2021 |
In vitro characterization of Pseudomonas aeruginosa recovered in Portugal from low respiratory tract infections in ICU patients (STEP Study).
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam | 2021 |
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Italy; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Whole Genome Sequencing | 2018 |
Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Tazobactam; Urinary Tract Infections | 2018 |
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; beta-Lactamases; Ceftazidime; Cephalosporins; Clone Cells; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Survival Analysis; Tazobactam | 2018 |
Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporin Resistance; Disk Diffusion Antimicrobial Tests; Drug Combinations; Humans; India; Penicillanic Acid; Respiratory Tract Infections; Sulbactam; Tazobactam; Urinary Tract Infections | 2012 |
Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1993 |
An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Disease Susceptibility; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 2001 |